Identification of Oral Lesions Through an Autofluorescence System
Use of a Tissue Autofluorescence Detection System for Identification of Oral Mucosal Lesions
1 other identifier
interventional
200
1 country
1
Brief Summary
The aim of the study will be to evaluate the efficacy of a tissue autofluorescence detection system as an aid to clinical screening in identifying lesions of the oral mucosa. The screening process will be performed by 3 clinicians with a different level of experience. Sensitivity and specificity tests will be conducted.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2023
CompletedFirst Submitted
Initial submission to the registry
June 29, 2023
CompletedFirst Posted
Study publicly available on registry
July 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2024
CompletedFebruary 28, 2024
February 1, 2024
9 months
June 29, 2023
February 26, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Clinical change of oral mucosa
Presence of a white, red, or mixed mucosal area with an exophytic or vegetative appearance or with loss of substance
baseline and after 21 days
Fluorescence change of oral mucosa
Presence of a mucosal area with reduced or increased fluorescence
baseline and after 21 day
Study Arms (1)
Screening examination
EXPERIMENTALAll patients will undergo a screening examination (with or without GOCCLES ® glasses) by all three operators.
Interventions
After an initial clinical visit, all three operators will wear the tissue autofluorescence detection device (GOCCLES®), reporting both observations on their "operator-module".
Eligibility Criteria
You may qualify if:
- Male and female;
- Age ≥ 18 years;
- Non-smokers and smokers
You may not qualify if:
- Cancer patients;
- Patients presenting a histological diagnosis of oral mucosal dysplasia/carcinoma.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Naples Federico II
Napoli, 80131, Italy
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SCREENING
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
June 29, 2023
First Posted
July 12, 2023
Study Start
June 1, 2023
Primary Completion
March 1, 2024
Study Completion
October 1, 2024
Last Updated
February 28, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share